Analisi delle conseguenze organizzative dell’introduzione di Ingenolo mebutato nello specifico contesto di cura italiano, in Valutazione dell’impatto clinico, economico, etico ed organizzativo dell’introduzione di una nuova tecnologia sanitaria, Ingenolo Mebutato, nel trattamento della cheratosi attinica in Italia

Translated title of the contribution: [Autom. eng. transl.] Analysis of the organizational consequences of the introduction of Ingenolo mebutato in the specific Italian treatment context, in Evaluation of the clinical, economic, ethical and organizational impact of the introduction of a new health technology, Ingenolo Mebutato, in the treatment of actinic keratosis in Italy

Maria Lucia Specchia, Chiara Cadeddu, Gualtiero Ricciardi, Anna Maria Ferriero, Agostino Mancuso, Emanuela Lovato, Flavia Kheiraoui

Research output: Working paper

Abstract

[Autom. eng. transl.] Ingenolo mebutato, summarizing the organizational and managerial advantages of topical therapies and outpatient treatments, in the face of a real and significant efficacy of the product, appears as an important therapeutic alternative for the treatment of AK, also in favor of categories of patients for whom other therapeutic solutions could be complex to implement, with a consequent reduction in the adherence and effectiveness of the treatment itself.
Translated title of the contribution[Autom. eng. transl.] Analysis of the organizational consequences of the introduction of Ingenolo mebutato in the specific Italian treatment context, in Evaluation of the clinical, economic, ethical and organizational impact of the introduction of a new health technology, Ingenolo Mebutato, in the treatment of actinic keratosis in Italy
Original languageItalian
Number of pages12
Publication statusPublished - 2013

Keywords

  • Actinic keratosis
  • Ingenol mebutate
  • health technology assessment
  • organisational impact

Fingerprint

Dive into the research topics of '[Autom. eng. transl.] Analysis of the organizational consequences of the introduction of Ingenolo mebutato in the specific Italian treatment context, in Evaluation of the clinical, economic, ethical and organizational impact of the introduction of a new health technology, Ingenolo Mebutato, in the treatment of actinic keratosis in Italy'. Together they form a unique fingerprint.

Cite this